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Objectives: In patients with peripheral arterial disease (PAD), abnormal muscle metabolism and impaired oxygen delivery
distal to the arterial occlusions may contribute to the exercise limitation observed in this population. Muscle tissue
hemoglobin saturation (StO2), measured with near-infrared spectroscopy, reflects the relative contributions of oxygen
delivery and oxygen use. Thus differences in the kinetics of StO2 in response to exercise may yield important insight into
the potential mechanisms associated with the PAD exercise impairment. The purposes of this study were to characterize
the muscle oxygenation responses in patients with PAD and in healthy control subjects at the onset of exercise, and to
compare the kinetics of StO2 desaturation. We hypothesized that at the onset of exercise the kinetics of StO2 desaturation
would be slowed in PAD compared with control responses.
Material and methods: Six patients with PAD and 6 healthy control subjects from a university center were examined in a
prospective cross-sectional analysis that evaluated the desaturation kinetics of StO2 at the onset of walking exercise. On
separate visits subjects performed graded treadmill exercise and 3 constant work rate treadmill tests equivalent to 60%
(low),80% (medium), and 100% (peak) of their peak exercise work rate. Gastrocnemious muscle StO2 response profiles
(InSpectra tissue spectrometer) were measured at rest and across the rest to exercise transition. Muscle StO2 responses
were characterized by an exponential mathematical model. The end point value was taken as the time constant of StO2
desaturation after onset of exercise (ie, equivalent to time to reach approximately 63% of StO2 decrease).
Results: The patients with PAD and the control subjects were of similar age and activity level. The qualitative patterns of
StO2 responses at onset of exercise were also similar between patients and control subjects at all work rates. However, the
kinetic time constants of StO2 desaturation were prolonged in patients with PAD versus control subjects (averaged time
constant across all work rates, 21.9  9.4 seconds vs 4.9  2.2 seconds; P < .01).
Conclusions: The slowed muscle StO2 kinetics in PAD are consistent with an impairment in muscle oxygen use at the onset
of walking exercise. Impaired muscle metabolism may contribute to the altered physiologic responses to exercise and to
exercise impairment in patients with PAD. (J Vasc Surg 2004;40:488-93.)Patients with peripheral arterial disease (PAD) and
claudication have a 50% reduction in peak exercise perfor-
mance that limits daily walking activities and functional
capacity.1 In PAD, atherosclerotic arterial occlusions limit
blood flow and oxygen delivery to the working muscles of
the leg during exercise. However, patients with PAD also
have increased oxidative stress and a spectrum of muscle
metabolic abnormalities that may have functional implica-
tions.2-4
Near-infrared spectroscopy (NIRS) has use in monitor-
ing local muscle hemoglobin oxygen saturation (StO2) at
rest and during exercise and recovery from exercise.5 Be-
cause muscle StO2 reflects the relative contributions of
oxygen delivery and oxygen use, differences in the dynamic
StO2 response across transitions from rest to exercise may
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doi:10.1016/j.jvs.2004.06.025488provide insight into the pathophysiologic features of the
exercise limitation in PAD. For example, in many patients
with PAD resting blood flow and the initial increment in
blood flow with low levels of exercise are not limited.6
Thus, in the absence of a defect in tissue oxygen use, the
dynamic StO2 responses immediately after onset of exercise
should be similar in patients with PAD and control sub-
jects. However, at higher work rates patients with PAD
cannot deliver sufficient blood flow and oxygen to meet
muscle metabolic demand. Under these conditions muscle
metabolism would require a rapid desaturation response as
oxygen extraction increases in the absence of an adequate
increase in oxygen delivery. In contrast, if PAD were asso-
ciated with impaired ability of muscle to use oxygen, the
rate of hemoglobin desaturation at onset of exercise would
be slowed. Thus quantitative differences in StO2 kinetics at
onset of exercise would identify whether a defect in meta-
bolic oxygen use contributes to the exercise pathophysio-
logic features of PAD.
METHODS
Subjects. Six men with PAD and 6 healthy men of
similar age and body mass index were included in the study,
which was approved by the Colorado Multiple Institutional
Review Board, and all subjects gave informed consent.
Patients with PAD were defined by resting ankle-brachial
index (ABI) less than 0.90, determined as the ratio of
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highest brachial systolic pressure. The index leg was defined
by the lowest ABI value in patients with PAD, and the
dominant leg in control subjects. All patients with PAD had
symptoms of claudication (pain or cramping in muscles of
the affected legs), which was the only limiting symptom
during graded treadmill exercise. Patients with diabetes or
who were taking -adrenergic antagonists were excluded,
because exercise responses are altered by these factors.7,8
Patients with PAD who were taking other medications were
not excluded, and the 6 patients in the PAD group included
5 patients who were taking a statin drug, and all 6 were
taking aspirin and antihypertensive drugs.
Exercise protocols. Subjects performed a graded
treadmill exercise test (Astrand protocol or Gardner proto-
col) to maximally tolerated workloads for identification of
peak exercise capacity (Q-stress; Quinton Instruments).9,10
On subsequent days subjects performed 6-minute constant
work rate (CWR) treadmill tests at workloads equal to
approximately 60% (low), 80% (medium), and 100% (peak)
of their peak exercise work rate. Thus the CWR exercise
tests were individualized to induce similar exercise intensity
(relative to peak exercise capacity) and thus a measurable
StO2 desaturation response. Systemic pulmonary gas ex-
change measurements of oxygen consumption (VO2), car-
bon dioxide production, and minute ventilation (CPX/D;
Medical Graphics) were measured to quantify the relative
exercise work rate of each CWR bout, as described.11
Arterial hemoglobin saturation was monitored and re-
corded with pulse oximetry during all exercise tests
(Ohmed Corp).
Skeletal muscle hemoglobin saturation. Non-
invasive muscle StO2 was measured with a continuous-
wave, near-infrared spectrometer (InSpectra model 325;
Hutchinson Technology). The NIRS signal is derived from
the hemoglobin in the microvasculature (precapillary, cap-
illary, postcapillary) of the tissue sampled, although contri-
bution from intracellular myoglobin cannot be definitively
excluded. Thus NIRS can be considered to reflect local
tissue oxygenation. The InSpectra tissue spectrometer was
modified for rapid sample measurement and data acquisi-
tion (6 Hz). Before each study the InSpectra device was
calibrated with a single light-scattering standard, and vali-
dated against standard references equivalent to 38% and
90% hemoglobin saturation. StO2 was determined with the
second derivative of the absorbance as a function of wave-
length at near-infrared wavelengths associated with
changes in oxyhemoglobin and deoxyhemoglobin or myo-
globin concentrations. The ratio of this second derivative at
720 and 760 nm has been empirically scaled to hemoglobin
saturation, and is used by the instrument to calculate the
reported StO2 values (User and Service Manual. Hutchin-
son Technology; 2004). Optical data were acquired with a
25-mm NIRS probe attached to the skin over the lateral
gastrocnemious muscle of the index limb with an adhesive
patch.
Analysis of StO2 kinetics. The 6-Hz StO2 data for
each individual CWR test were time-bin averaged to yield1-Hz data files. With a statistical graphing program (Sig-
maplot 2002), a 2-component mathematical curve-fitting
model was used to describe the StO2 kinetic response with
nonlinear regression techniques.
StO2(t) StO2(b)A1(1 e(tTD1) ⁄1)
A2(1 e(tTD2) ⁄2)
In each curve fit (Fig, B), StO2(b) was the resting
baseline value. After onset of exercise there was an initial
time delay (TD1), followed by a primary desaturation in
StO2 (below baseline), described with an exponential time
constant (1) representing the time to reach 63% of the
desaturation response. The difference between the resting
StO2 and the nadir of the primary StO2 desaturation was
calculated as A1. Where a subsequent StO2 increase was
observed, a second exponential function (Eq 2) was used so
that the overall model would allow a best fit of the primary
StO2 desaturation response. Data for A2, TD2, and 2, are
not presented, but contributed to the model that yielded
the reported values for A1, TD1, and 1.
RESULTS
Patients with PAD were of similar age (66 7 years) as
control subjects (65 7 years), but had a lower ABI in the
index leg (0.62  0.13 vs 1.24  0.08 in control subjects;
P .01) and reduced peak exercise oxygen uptake (16.4
4.2 mL/kg/min) compared with control subjects (26.0 
4.2 mL/kg/min; P  .01). No subject demonstrated
arterial hemoglobin desaturation during any of the exercise
tests.
The qualitative patterns of the initial StO2 response
were similar between groups during low, medium, and
peak CWR exercise (Fig). At low CWR, 3 healthy subjects
and 1 patient with PAD demonstrated an StO2 profile with
no desaturation below baseline levels (Fig, A and D). One
control subject demonstrated no desaturation response
below baseline levels during medium CWR exercise. The
remaining control subjects and patients with PAD exhib-
ited a desaturation response at all work rates. After onset of
exercise (eg, Fig, B), there was an initial increase in StO2
(characterized by TD1), which was followed by a rapid
decrease in StO2 to a plateau below baseline (StO2 nadir).
In control subjects the nadir of StO2 desaturation typically
occurred within 40 seconds, followed by a slow phase of
increase in StO2. In contrast, the initial StO2 desaturation
was slower in patients with PAD, reaching a nadir at ap-
proximately 100 seconds into exercise (Fig, E and F). The
StO2 nadir was similar at the same relative work rates
between PAD and control groups, with the total decrease
in StO2 proportionate to increases in exercise intensity.
However, as previously reported, the magnitude of StO2
desaturation at similar absolute work rates was greater in
patients with PAD than in control subjects.12 Specifically,
the StO2 desaturation with peak CWR exercise in patients
with PAD was greater than observed during low CWR
exercise in control subjects (A1 –18% controls vs –44%
PAD), despite similar absolute work rates performed (1330
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September 2004490 Bauer, Brass, and HiattMuscle oxygen saturation responses (StO2) from a representative patient with peripheral artery disease and a control
subject during low (A, D), medium (B, E), and peak (C, F) constant work rate exercise. Exercise was initiated at time
0 (vertical dashed line). During low constant work rate exercise there was no decrease in StO2. With the higher work
rates there was an initial increase, followed by a rapid decrease in StO2. StO2(b), Baseline; TD1, time delay (seconds)
during period of increase in StO2; A1, difference between baseline and nadir of initial StO2 desaturation; 1, time
constant of StO desaturation.2
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mL/min for control subjects).
Control subjects had a short time delay and rapid StO2
time constant (1), which was consistent between subjects
and independent of work intensity (Table). In contrast,
patients with PAD had a longer time delay and slowed StO2
desaturation kinetics that displayed considerable heteroge-
neity between patients with PAD. Nonetheless, within the
PAD cohort as a whole, or when analyzed on an individual
subject basis, there was no relationship between 1 and
workload. The StO2 time constant (1) was statistically
different between patients with PAD and control subjects
at low and medium CWR (P .05), and tended to separate
at peak CWR (P .14). Inasmuch as the time constant did
not vary as a function of increasing workload in individual
subjects, the time constants for all CWR tests performed by
an individual were averaged to yield the best estimate for
this parameter for each subject. Analyzed in this manner,
the time constant average was 4.9 2.2 seconds for control
subjects and 21.9  9.4 seconds for patients with PAD
(n  6 per group; P  .01).
DISCUSSION
This study demonstrated that while muscle StO2 re-
sponses at the onset of treadmill exercise are qualitatively
similar between patients with PAD and control subjects,
the kinetics of StO2 desaturation were markedly slowed in
the PAD group. In both groups a low relative work rate
could be identified in selected subjects that was not associ-
ated with StO2 desaturation below resting values. Thus
workloads could be identified in which patients with PAD
Constant work rate StO2 characteristics
Cont
Mean  SD
Low N  3
Work intensity (% peak VO2) 58  15
StO2(b) 50  10
1 (s) 4.0  0.9
TD1 (s) 13.9  3.1
A1 (%) 18  5
Medium N  5
Work intensity (% peak VO2) 86  5
StO2(b) 63  9
1 (s) 5.2  2.8
TD1 (s) 8.7 3.4
A1 (%) 38  10
Peak (100% peak VO2) N  6
StO2(b) 66  14
1 (s) 5.7  3.1
TD1 (s) 8.3 4.0
A1 (%) 41  9
Three control subjects and 1 patient with PAD had no desaturation respon
calculated.
PAD, Peripheral arterial disease; StO2(b), resting muscle oxygenation (%); V
of StO2 response.
*P  .05, PAD vs control.
†P  .01, PAD vs control.
‡P  .14, PAD vs control.appeared to have increases in blood flow that matched
oxygen demand, resulting in no StO2 desaturation. At
higher relative work rates all subjects had StO2 responses
characterized by an initial increase in StO2 saturation fol-
lowed by a primary decrease in StO2, the magnitude of
which increased with increasing relative exercise intensity.
In contrast, the StO2 kinetic responses (time constants) in
both groups appeared independent of the relative work
rate, and remained slowed even at similar absolute work
rates, which suggests that the observed differences in StO2
kinetic responses cannot be explained solely on the basis of
a difference in absolute work performed. Thus, whether the
groups were compared at the same absolute or relative work
rates, the time constants were clearly different, which sup-
ports the conclusion that the differences in StO2 kinetics
observed reflects the PAD population and not the absolute
workloads evaluated.
Previous investigations have described a greater de-
crease in muscle oxygenation during incremental exercise
and slowed StO2 dynamics in recovery from exercise in
PAD, attributing these differences from healthy subjects to
the impaired hemodynamics of the PAD condition.12,13
The current study confirms the greater decrement in StO2
observed in patients with PAD at similar absolute work
rates. However, the analysis of metabolic processes during
recovery from exercise is complicated by the clear differ-
ences in blood flow between PAD and control groups
provoked by higher workloads, and the accumulation of
lactate and other metabolic intermediates that can modu-
late cellular metabolism associated with the exercise bout.
In contrast, our approach provided a unique perspective on
PAD
Range Mean  SD Range
N  5
43-73 68 17 48-90
38-57 53 10 42-60
2.9-4.6 24.0 2.9† 19.9-28.1
11.0-17.2 27.6 9.4* 14.9-37.0
13-23 22  3 14-26
N  6
78-93 77 13 56-93
52-70 54 6 46-59
1.8-9.5 20.0 12* 9.3-42.4
3.7-11.8 21.6 10.7* 10.5-39.7
20-48 32  14 17-56
N  6
50-89 55 10 37-64
2.4-11.0 19.2 18.6‡ 6.7-53.5
5.3-15.5 13.2 11.2 0.0-29.9
29-57 44  17 20-65
ring low constant work rate exercise, and thus no kinetic parameters were
ume of oxygen use; 1, StO2 time constant; TD1, time delay; A1, amplituderol
se du
O2, vol
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factors at the onset of exercise that may contribute to the
exercise limitation in PAD.
Patients with intermittent claudication have relatively
normal resting lower limb blood flow, and blood flow can
increase with exercise.6 However, as exercise continues,
arterial occlusions restrict exercise hyperemia, and oxygen
delivery reaches a plateau.6 When increases in metabolic
demand exceed increases in oxygen delivery, muscle oxy-
gen extraction increases, as reflected by a decrease in StO2.
Thus in PAD a limitation in oxygen delivery at the onset of
exercise would be expected to accelerate the rate of StO2
desaturation within the muscle, provided that oxygen dif-
fusion and mitochondrial function were normal. This re-
sponse was not observed in this cohort of patients with
PAD (Fig; Table), despite reports of increased muscle
capillary density and thus potentially enhanced microvascu-
lar oxygen diffusion in this patient population.14 In con-
trast, the slowed rate of StO2 desaturation after onset of
treadmill exercise in patients with PAD may be explained by
the abnormalities of muscle oxidative metabolism previ-
ously described in this patient group. For example, patients
with PAD have alterations in the regulation of oxidative
adenosine triphosphate generation, abnormalities of elec-
tron transport chain enzyme activities, and an accumulation
of short-chain acylcarnitines in affected skeletal muscle,
which are inversely correlated with exercise perfor-
mance.3,4,15 The inherent delay to increase muscle oxida-
tive metabolism in the face of increasing adenosine triphos-
phate requirements has been termed “metabolic inertia,”
and has been hypothesized to be an important physiologic
characteristic of the exercise response.16,17 These observa-
tions support the concept that patients with PAD develop a
mitochondrial myopathy. Moreover, these findings sup-
port previous reports of slowed pulmonary oxygen uptake
kinetics in PAD11,18,19 and extend these observations to
suggest that metabolic abnormalities specific to the affected
skeletal muscle in PAD may contribute in part to the
observed exercise limitation in this patient population.
Limitations. Factors other than the balance between
oxygen delivery and oxygen use may influence the inte-
grated StO2 measurement at onset of exercise. Although
the StO2 signal is empirically scaled to hemoglobin satura-
tion, the contribution of myoglobin cannot be definitively
excluded, and its proportion to the overall NIRS signal
remains a topic of controversy. Without entering into this
debate, NIRS measurements can be considered to reflect
local tissue oxygenation inclusive of hemoglobin and myo-
globin. Thus we consider our measurements to reflect a
general view of muscle StO2, and cannot address interac-
tions between microvascular and intracellular oxygen
stores. The StO2 measurement may also be influenced by
the redistribution of oxyhemoglobin and deoxyhemoglo-
bin within the sample window representing a mixture of
capillary and venular blood with different saturations.20 For
example, at onset of exercise, activation of the muscle pump
was associated with a rapid decrease in the total absorbance
of hemoglobin (data not shown), and thus may in partexplain the transient increase in muscle StO2 observed
immediately after exercise onset.
CONCLUSIONS
In patients with PAD, StO2 desaturation kinetics were
slowed at the onset of treadmill exercise, consistent with
impaired muscle oxygen use. These findings provide fur-
ther evidence of the interplay between the metabolic and
hemodynamic factors that may contribute to the exercise
impairment in patients with PAD. Muscle metabolic func-
tion may be an important therapeutic target in PAD.17,21
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